NASDAQ : FATE
Fate Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.17 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 260.01M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Fate Therapeutics, Inc. (FATE) reported revenue of 6.49M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 6.49M | 6.65M | 13.63M | 63.53M | 96.30M | 55.85M |
| Cost of Revenue | 84.42M | 91.90M | 118.53M | 157.19M | 320.45M | 215.52M |
| Gross Profit | -77.93M | -85.25M | -104.90M | -93.65M | -224.15M | -159.67M |
| Selling, General & Admin | 54.56M | 61.35M | 90.64M | 96.86M | 84.23M | 57.32M |
| Operating Expenses | 54.56M | 61.35M | 90.64M | 96.86M | 84.23M | 57.32M |
| Operating Income | -132.49M | -146.60M | -195.54M | -190.51M | -308.39M | -216.99M |
| Interest & Investment Income | 8.22M | 11.05M | 17.29M | 17.19M | 5.84M | 1.31M |
| Other Non Operating Income (Expenses) | -623.00K | 337.00K | 6.73M | 7.30M | 20.32M | 3.53M |
| EBT Excluding Unusual Items | -124.90M | -135.22M | -171.53M | -166.03M | -282.22M | -212.15M |
| Merger & Restructuring Charges | -1.10M | -1.10M | ||||
| Asset Writedown | -14.74M | |||||
| Other Unusual Items | 5.10M | 500.00K | ||||
| Pretax Income | -126.00M | -136.31M | -186.26M | -160.93M | -281.72M | -212.15M |
| Net Income | -126.00M | -136.31M | -186.26M | -160.93M | -281.72M | -212.15M |
| Net Income to Common | -126.00M | -136.31M | -186.26M | -160.93M | -281.72M | -212.15M |
| Shares Outstanding (Basic) | 119.67M | 118.79M | 113.69M | 98.41M | 96.83M | 94.75M |
| Shares Outstanding (Diluted) | 119.67M | 118.79M | 113.69M | 98.41M | 96.83M | 94.75M |
| EPS (Basic) | -1.05 | -1.15 | -1.64 | -1.64 | -2.91 | -2.24 |
| EPS (Diluted) | -1.05 | -1.15 | -1.64 | -1.64 | -2.91 | -2.24 |
| Free Cash Flow | -105.66M | -112.04M | -123.60M | -138.42M | -283.77M | -213.57M |
| Free Cash Flow Per Share | -0.88 | -0.94 | -1.09 | -1.41 | -2.93 | -2.25 |
| Gross Margin | -147.41% | -232.77% | -285.92% | |||
| Operating Margin | -2,041.13% | -2,205.90% | -1,434.52% | -299.86% | -320.24% | -388.56% |
| Profit Margin | -1,941.09% | -2,051.08% | -1,366.46% | -253.30% | -292.55% | -379.89% |
| Free Cash Flow Margin | -1,627.76% | -1,685.78% | -906.79% | -217.87% | -294.68% | -382.43% |
| EBITDA | -120.50M | -133.70M | -176.58M | -172.23M | -294.63M | -211.14M |
| EBITDA Margin | -271.09% | |||||
| D&A For EBITDA | 11.99M | 12.90M | 18.96M | 18.28M | 13.76M | 5.85M |
| EBIT | -132.49M | -146.60M | -195.54M | -190.51M | -308.39M | -216.99M |
| EBIT Margin | -299.86% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 32.43M | 46.63M | 36.06M | 41.87M | 61.33M | 133.58M |
| Short-Term Investments | 121.34M | 157.03M | 243.01M | 273.31M | 374.89M | 482.33M |
| Cash & Short-Term Investments | 153.77M | 203.66M | 279.07M | 315.18M | 436.23M | 615.91M |
| Accounts Receivable | 703.00K | 916.00K | 3.54M | 1.83M | 38.48M | 8.68M |
| Other Receivables | 300.00K | 700.00K | 2.10M | 900.00K | 800.00K | 1.10M |
| Receivables | 1.00M | 1.62M | 5.64M | 2.73M | 39.28M | 9.78M |
| Prepaid Expenses | 3.18M | 3.43M | 7.20M | 13.64M | 26.57M | 7.73M |
| Total Current Assets | 157.95M | 208.70M | 291.91M | 331.54M | 502.07M | 633.41M |
| Property, Plant & Equipment | 92.10M | 98.53M | 110.89M | 158.51M | 176.09M | 162.25M |
| Long-Term Investments | 1.47M | 27.66M | 980.00K | 4.94M | 100.66M | |
| Long-Term Deferred Charges | 7.20M | 9.87M | ||||
| Other Long-Term Assets | 10.05M | 10.23M | 10.24M | 15.19M | 15.26M | 15.26M |
| Total Assets | 260.10M | 318.94M | 440.69M | 506.22M | 705.56M | 921.46M |
| Accounts Payable | 3.26M | 2.66M | 9.37M | 4.72M | 8.27M | 8.61M |
| Accrued Expenses | 14.90M | 20.02M | 21.35M | 27.51M | 53.93M | 42.41M |
| Current Portion of Leases | 4.92M | 4.56M | 7.42M | 6.18M | 5.63M | 5.58M |
| Current Unearned Revenue | 381.00K | 393.00K | 685.00K | 42.23M | 21.48M | |
| Other Current Liabilities | 9.51M | 8.45M | 4.00M | 3.20M | ||
| Total Current Liabilities | 32.59M | 36.07M | 38.52M | 39.09M | 114.05M | 81.28M |
| Long-Term Leases | 70.75M | 73.29M | 77.85M | 97.36M | 103.71M | 109.24M |
| Long-Term Unearned Revenue | 27.12M | |||||
| Other Long-Term Liabilities | 3.32M | 2.40M | 5.60M | 1.35M | 3.86M | 24.97M |
| Total Liabilities | 106.67M | 111.75M | 121.97M | 137.80M | 221.62M | 242.62M |
| Common Stock | 117.00K | 115.00K | 114.00K | 99.00K | 97.00K | 96.00K |
| Additional Paid-In Capital | 1.75B | 1.74B | 1.72B | 1.58B | 1.54B | 1.45B |
| Retained Earnings | -1.60B | -1.53B | -1.40B | -1.21B | -1.05B | -769.08M |
| Comprehensive Income & Other | -117.00K | 116.00K | 268.00K | 15.00K | -1.85M | -762.00K |
| Total Common Equity | 153.44M | 207.18M | 318.72M | 368.41M | 483.94M | 678.84M |
| Shareholders' Equity | 153.44M | 207.18M | 318.73M | 368.42M | 483.94M | 678.84M |
| Total Liabilities & Equity | 260.10M | 318.94M | 440.69M | 506.22M | 705.56M | 921.46M |
| Total Debt | 75.67M | 77.85M | 85.27M | 103.54M | 109.34M | 114.82M |
| Net Cash (Debt) | 78.09M | 125.81M | 193.80M | 211.64M | 326.89M | 501.09M |
| Net Cash Per Share | 0.65 | 1.06 | 1.70 | 2.15 | 3.38 | 5.29 |
| Filing Date Shares Outstanding | 119.82M | 116.26M | 114.60M | 99.24M | 98.16M | 96.43M |
| Total Common Shares Outstanding | 116.69M | 115.36M | 113.93M | 98.63M | 97.29M | 95.73M |
| Working Capital | 125.36M | 172.63M | 253.39M | 292.45M | 388.02M | 552.13M |
| Book Value Per Share | 1.31 | 1.80 | 2.80 | 3.74 | 4.97 | 7.09 |
| Tangible Book Value | 153.44M | 207.18M | 318.72M | 368.41M | 483.94M | 678.84M |
| Tangible Book Value Per Share | 1.31 | 1.80 | 2.80 | 3.74 | 4.97 | 7.09 |
| Machinery | 29.61M | 38.85M | 83.29M | 81.50M | 53.63M | |
| Leasehold Improvements | 62.35M | 59.48M | 59.04M | 56.78M | 52.95M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -126.00M | -136.31M | -186.26M | -160.93M | -281.72M | -212.15M |
| Depreciation & Amortization | 11.99M | 12.90M | 18.96M | 18.28M | 13.76M | 5.85M |
| Other Amortization | 7.20M | 2.68M | 4.00M | |||
| Loss (Gain) From Sale of Assets | 45.00K | 9.00K | 942.00K | |||
| Asset Writedown & Restructuring Costs | 14.74M | |||||
| Loss (Gain) From Sale of Investments | -3.23M | -3.61M | -9.08M | -11.40M | -256.00K | 5.07M |
| Stock-Based Compensation | 17.84M | 24.92M | 41.50M | 43.46M | 78.73M | 54.36M |
| Other Operating Activities | 622.00K | -256.00K | -1.71M | -48.06M | -26.69M | -22.09M |
| Change in Accounts Receivable | 693.00K | 2.62M | -1.11M | 36.65M | -29.80M | -3.16M |
| Change in Accounts Payable | -4.20M | -9.03M | -1.66M | -28.94M | 14.25M | 5.91M |
| Change in Other Net Operating Assets | 298.00K | 2.66M | 816.00K | 11.47M | -19.16M | -649.00K |
| Operating Cash Flow | -101.94M | -106.08M | -122.87M | -132.26M | -248.21M | -162.87M |
| Capital Expenditures | -3.71M | -5.95M | -730.00K | -6.15M | -35.57M | -50.70M |
| Sale of Property, Plant & Equipment | 240.00K | 362.00K | ||||
| Investment in Securities | 90.52M | 116.76M | 12.95M | 118.82M | 202.32M | -273.32M |
| Investing Cash Flow | 87.05M | 111.17M | 12.22M | 112.67M | 166.75M | -324.02M |
| Issuance of Common Stock | 412.00K | 74.83M | 85.00K | 9.21M | 432.45M | |
| Other Financing Activities | 5.49M | 5.49M | 25.07M | 20.68M | ||
| Financing Cash Flow | 5.90M | 5.49M | 99.89M | 85.00K | 9.21M | 453.13M |
| Net Cash Flow | -9.00M | 10.57M | -10.76M | -19.51M | -72.25M | -33.76M |
| Free Cash Flow | -105.66M | -112.04M | -123.60M | -138.42M | -283.77M | -213.57M |
| Free Cash Flow Margin | -1,627.76% | -1,685.78% | -906.79% | -217.87% | -294.68% | -382.43% |
| Free Cash Flow Per Share | -0.88 | -0.94 | -1.09 | -1.41 | -2.93 | -2.25 |
| Levered Free Cash Flow | -48.66M | -51.56M | -60.77M | -82.31M | -148.77M | -134.71M |
| Unlevered Free Cash Flow | -48.66M | -51.56M | -60.77M | -82.31M | -148.77M | -134.71M |
| Change in Working Capital | -3.21M | -3.74M | -1.96M | 19.18M | -34.71M | 2.10M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 240.84M | 113.35M | 187.93M | 368.77M | 980.45M | 5.59B |
| Enterprise Value | 162.74M | -22.83M | -10.02M | 123.99M | 586.24M | 5.02B |
| Last Close Price | 2.08 | 0.98 | 1.65 | 3.74 | 10.09 | 58.51 |
| PS Ratio | 37.57 | 17.05 | 13.79 | 5.80 | 10.18 | 100.05 |
| PB Ratio | 1.58 | 0.55 | 0.59 | 1.00 | 2.03 | 8.23 |
| P/TBV Ratio | 1.59 | 0.55 | 0.59 | 1.00 | 2.03 | 8.23 |
| EV/Sales Ratio | 25.53 | 1.95 | 6.09 | 89.85 | ||
| Debt / Equity Ratio | 0.49 | 0.38 | 0.27 | 0.28 | 0.23 | 0.17 |
| Net Debt / Equity Ratio | -0.51 | -0.61 | -0.61 | -0.57 | -0.68 | -0.74 |
| Net Debt / EBITDA Ratio | 0.65 | 0.94 | 1.10 | 1.23 | 1.11 | 2.37 |
| Net Debt / FCF Ratio | 0.74 | 1.12 | 1.57 | 1.53 | 1.15 | 2.35 |
| Asset Turnover | 0.02 | 0.02 | 0.03 | 0.10 | 0.12 | 0.07 |
| Quick Ratio | 4.75 | 5.69 | 7.39 | 8.13 | 4.17 | 7.70 |
| Current Ratio | 4.85 | 5.79 | 7.58 | 8.48 | 4.40 | 7.79 |
| Return on Equity (ROE) | -60.75% | -51.84% | -54.21% | -37.76% | -48.46% | -39.91% |
| Return on Assets (ROA) | -26.21% | -24.12% | -25.81% | -19.65% | -23.69% | -17.57% |
| Return on Capital Employed (ROCE) | -58.20% | -51.80% | -48.60% | -40.80% | -52.10% | -25.80% |
| Earnings Yield | -52.38% | -120.27% | -99.11% | -43.64% | -28.73% | -3.80% |
| FCF Yield | -43.33% | -98.85% | -65.77% | -37.53% | -28.94% | -3.82% |
| Buyback Yield / Dilution | -1.19% | -4.49% | -15.52% | -1.64% | -2.19% | -15.00% |